| Released | Contributor | Author | Title | Pages | Price |
| 19-Dec-2009 | PriceTarget Research, Inc. |
N/A
| Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 17-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: TARO PHARMACEUT -- TAROF | 1 |
$4 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ACCL , ANPI , PRX , PBH , TAROF , TGX , VVUS -- DRUGS | 3 |
$4 |
| 14-Dec-2009 | Reuters Investment Profile |
N/A
| Taro Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 11-Dec-2009 | Validea |
N/A
| Validea Guru Analysis Report for TAROF. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. | 0 |
$18 |
0.20% Nasdaq 
Research Reports
